Detalles de la búsqueda
1.
Survival with Cemiplimab in Recurrent Cervical Cancer.
N Engl J Med
; 386(6): 544-555, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139273
2.
Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.
Nature
; 626(7997): 30-32, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291141
3.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med
; 385(20): 1856-1867, 2021 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34534429
4.
Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study.
BMC Cancer
; 24(1): 750, 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38902624
5.
[18F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
BMC Cancer
; 24(1): 513, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654241
6.
Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
BMC Cancer
; 24(1): 655, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811880
7.
A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
BMC Cancer
; 24(1): 626, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783223
8.
Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
BMC Cancer
; 24(1): 589, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745137
9.
Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
Gynecol Oncol
; 184: 214-223, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340647
10.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Gynecol Oncol
; 184: 224-235, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340648
11.
Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
Am J Obstet Gynecol
; 230(6): 663.e1-663.e13, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365097
12.
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
Int J Gynecol Cancer
; 34(6): 817-823, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649234
13.
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
Mol Cell
; 63(3): 514-25, 2016 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27453043
14.
Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients.
Int J Med Sci
; 21(8): 1428-1437, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38903932
15.
Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
J Endocrinol Invest
; 47(6): 1545-1557, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170396
16.
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Int J Clin Oncol
; 29(5): 620-628, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530569
17.
Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
BMC Public Health
; 24(1): 1349, 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764017
18.
Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.
BMC Health Serv Res
; 24(1): 693, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822370
19.
The intersection of race/ethnicity and socioeconomic status: inequalities in breast and cervical cancer mortality in 20,665,005 adult women from the 100 Million Brazilian Cohort.
Ethn Health
; 29(1): 46-61, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642313
20.
Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
J Obstet Gynaecol
; 44(1): 2361858, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38864403